Treatment of Central Serous Chorioretinopathy - Our Experience
O. Chrapek; J. Řehák
Oční klinika FN a LF UP, Olomouc, přednosta doc. MUDr. J. Řehák, CSc.
Čes. a slov. Oftal., , 2002, No. 1, p. 51-56
On a group of 18 eyes the authors evaluate their experience with medicamentousand laser therapy of central serous chorioretinopathy. They report unsatisfactoryresults in the group of patients treated with non-steroid antiphlogistics, resor-bents, vasoprotective agents, vitamins, where they observed adherence of ablatedneuroepithelium in 4 eyes on average after 5.5 weeks. But in 7 similarly treatedeyes adherence of the ablation did not occur even after 4 months. The authorsconfirm the value of direct laser photocoagulation for reducing the period ofablation in central serous chorioretinopathy. In all 11 photocoagulations oftreatedeyes theablation adheredonaverageafter 5.2 weeks. Theauthors maintainthat they achieved better final visual acuity and greater improvement of visualacuity in patients where the ablation period of the neuroepithelium was shorterthan in patients with a prolonged course of ablation.
central serous chorioretinopathy, medicamentous, laser therapy
Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP